Status:
ENROLLING_BY_INVITATION
The Correlation Between CT and MRCP Before Living Liver Donation for Liver Blood Vessel Assessment: an Ambidirectional Cohort Study
Lead Sponsor:
Erasmus Medical Center
Conditions:
Living Donor Liver Transplantation
Eligibility:
All Genders
18-60 years
Brief Summary
Living donor liver transplantation (LDLT) is a good solution to the donor liver shortage in the Netherlands. In cases of severe liver disease, LDLT has substantial survival benefits, fewer (future) co...
Detailed Description
Research methods: Data, CT-and MRCP images will be extracted from HiX. Screenshots of the images will be made. All personal data will be blacked out using Microsoft Powerpoint 16.90.2. The CT- and MR...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Living liver donation between May 2004 and June 2026
- Written informed consent
- In order to be eligible for LDLT, a subject needed to meet all of the following criteria:
- 18-60 years old
- Physical and mental well-being
- Body Mass Index (BMI) \<33 kg/m2
- No active drugs or other substances use
Exclusion
- There are no exclusion criteria for this study.
- Exclusion criteria for LDLT were:
- Absolute exclusion criteria
- Medical conditions (for instance heart disease and bleeding or clotting disorders)
- History of liver disease
- Previous/active malaria infection
- Financial incentive or indications of pressure
- Unable to cooperate with designated long-term follow-up
- Severe psychiatric disease or psychological instability
- Active alcoholism or frequent heavy alcohol use or drugs use/abuse
- Unable to give informed consent
- History of dementia or other neurological degenerative disorders
- Persons with rabies or persons bitten in the past 6 months by an animal and that are treated as if the animal is rabid
- Persons with syphilis
- Human immunodeficiency virus-positive persons. Relative exclusion criteria
- BMI \>33 kg/m2
- Smoking
Key Trial Info
Start Date :
January 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06875232
Start Date
January 1 2026
End Date
December 31 2027
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus Medical Center
Rotterdam, South Holland, Netherlands, 3015 GD